These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Real-time electronic ambulatory monitoring of substance use and symptom expression in schizophrenia. Swendsen J, Ben-Zeev D, Granholm E. Am J Psychiatry; 2011 Feb; 168(2):202-9. PubMed ID: 21078705 [Abstract] [Full Text] [Related]
3. The effect of marijuana use on the risk for schizophrenia. Evins AE, Green AI, Kane JM, Murray RM. J Clin Psychiatry; 2012 Nov; 73(11):1463-8. PubMed ID: 23218162 [No Abstract] [Full Text] [Related]
11. [Cannabis and Schizophrenia: new findings in an old debate]. Kawohl W, Rössler W. Neuropsychiatr; 2008 Jan; 22(4):223-9. PubMed ID: 19080993 [Abstract] [Full Text] [Related]
16. Cannabis and risk of psychosis. Drewe M, Drewe J, Riecher-Rössler A. Swiss Med Wkly; 2004 Nov 13; 134(45-46):659-63. PubMed ID: 15611887 [Abstract] [Full Text] [Related]
17. High potency cannabis: a risk factor for dependence, poor psychosocial outcomes, and psychosis. Hall W, Degenhardt L. BMJ; 2015 Mar 04; 350():h1205. PubMed ID: 25739398 [No Abstract] [Full Text] [Related]